AbCellera Biologics Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ABCL Nasdaq 8731 https://www.abcellera.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AbCellera Biologics Inc

Could The AbCellera Biologics Inc. (NASDAQ:ABCL) Ownership Structure Tell Us Something Useful? - Oct 16th, 2021 12:05 pm
AbCellera to Report Third Quarter 2021 Financial Results on November 9, 2021 - Oct 14th, 2021 8:05 pm
Harvard University Stock Portfolio: Top 10 Picks - Oct 11th, 2021 1:18 pm
Why AbCellera Biologics Stock Jumped 19.4% Last Month - Oct 7th, 2021 11:59 am
AbCellera, Everest Medicines Team Up To Develop 10 Therapeutic Antibodies - Sep 23rd, 2021 1:59 pm
AbCellera and Everest Medicines Announce Multi-Target Collaboration to Advance New Antibody Therapies - Sep 22nd, 2021 10:00 pm
Lilly to Supply the EU and EEA with up to 220,000 Doses of AbCellera-Discovered Bamlanivimab Together with Etesevimab for the Treatment of Confirmed COVID-19 - Sep 21st, 2021 5:55 pm
FDA’s Call on Lilly’s Covid Drug Is Lifting a Partner’s Beaten-Down Stock - Sep 17th, 2021 1:57 pm
15 Stocks Moving in Friday's Pre-Market Session - Sep 17th, 2021 11:06 am
Premarket Movers Friday - Take-Two, Lucid, Invesco, AbCellera - Sep 17th, 2021 8:53 am
Emergency Use Authorization of AbCellera-Discovered Bamlanivimab Administered with Etesevimab Expanded by the FDA to Include Post-Exposure Prophylaxis for the Prevention of COVID-19 - Sep 16th, 2021 8:15 pm
AbCellera, Kymera and Diamondback Move in After-Hours - Sep 16th, 2021 5:43 pm
Why AbCellera Biologics Stock Jumped 7% on Wednesday - Sep 15th, 2021 10:33 pm
AbCellera Announces Collaboration with Moderna to Discover Therapeutic Antibodies for mRNA Medicines - Sep 15th, 2021 1:00 pm
AbCellera Acquires TetraGenetics, Enhancing Capabilities to Generate Antibodies Against High-Value Targets - Sep 13th, 2021 1:00 pm
AbCellera to Present Virtually at the BofA Securities – Tech Solutions for Drug Discovery Conference - Sep 10th, 2021 8:17 pm
Here's Why AbCellera Biologics Stock Gained 10.6% Last Month - Sep 4th, 2021 3:12 pm
Analysts Are More Bearish On AbCellera Biologics Inc. (NASDAQ:ABCL) Than They Used To Be - Aug 17th, 2021 10:00 am
Is AbCellera Biologics Inc. (NASDAQ:ABCL) A High Quality Stock To Own? - Aug 14th, 2021 7:03 am
Why AbCellera Biologics Stock Was Up More Than 17% on Friday - Aug 13th, 2021 4:52 pm